Overview

The Childhood and Adolescent Migraine Prevention Study

Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test two medicines for migraine prevention in children and adolescents.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Amitriptyline
Amitriptyline, perphenazine drug combination
Topiramate